Arpin deficiency increases actomyosin contractility and vascular permeability
eLife · 2024
DOI: 10.7554/elife.90692 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2024. Verfasst von Armando Montoya-Garcia und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biomedicine, CINVESTAV-IPN, Mexico City, Mexico. Hauptthemen laut MEDLINE: Capillary Permeability, Actomyosin, Human Umbilical Vein Endothelial Cells. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Consejo Nacional de Ciencia y Tecnología.
Abstract (Originalsprache)
Arpin was discovered as an inhibitor of the Arp2/3 complex localized at the lamellipodial tip of fibroblasts, where it regulated migration steering. Recently, we showed that arpin stabilizes the epithelial barrier in an Arp2/3-dependent manner. However, the expression and functions of arpin in endothelial cells (EC) have not yet been described. Arpin mRNA and protein are expressed in EC and downregulated by pro-inflammatory cytokines. Arpin depletion in Human Umbilical Vein Endothelial Cells causes the formation of actomyosin stress fibers leading to increased permeability in an Arp2/3-independent manner. Instead, inhibitors of ROCK1 and ZIPK, kinases involved in the generation of stress fibers, normalize the loss-of-arpin effects on actin filaments and permeability. Arpin-deficient mice are viable but show a characteristic vascular phenotype in the lung including edema, microhemorrhage, and vascular congestion, increased F-actin levels, and vascular permeability. Our data show that, apart from being an Arp2/3 inhibitor, arpin is also a regulator of actomyosin contractility and endothelial barrier integrity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Biomedicine, CINVESTAV-IPN, Mexico City, Mexico.
- Department of Infectomics and Molecular Pathogenesis, CINVESTAV-IPN, Mexico City, Mexico.
- Department of Biochemistry, CINVESTAV-IPN, Mexico City, Mexico.
- Laboratorio de Patogénesis Molecular, Facultad de Estudios Superiores de Iztacala, Tlalnepantla de Baz, Mexico.
ORCID-Profile: Armando Montoya-Garcia, Idaira M Guerrero-Fonseca, Abigail Betanzos, Michael Schnoor
Förderung
- Consejo Nacional de Ciencia y Tecnología
Zitieren
APA
Montoya-Garcia, A., Guerrero-Fonseca, I. M., Chanez-Paredes, S. D., Hernandez-Almaraz, K. B., Leon-Vega, I. I., Silva-Olivares, A., Betanzos, A., Mondragon-Castelan, M., Mondragon-Flores, R., Salinas-Lara, C., Vargas-Robles, H., & Schnoor, M. (2024). Arpin deficiency increases actomyosin contractility and vascular permeability. eLife. https://doi.org/10.7554/elife.90692
Vancouver
Montoya-Garcia A, Guerrero-Fonseca IM, Chanez-Paredes SD, Hernandez-Almaraz KB, Leon-Vega II, Silva-Olivares A, et al. Arpin deficiency increases actomyosin contractility and vascular permeability. eLife. 2024. doi:10.7554/elife.90692
BibTeX
@article{MontoyaGarcia2024,
author = {Montoya-Garcia, Armando and Guerrero-Fonseca, Idaira M and Chanez-Paredes, Sandra D and Hernandez-Almaraz, Karina B and Leon-Vega, Iliana I and Silva-Olivares, Angelica and Betanzos, Abigail and Mondragon-Castelan, Monica and Mondragon-Flores, Ricardo and Salinas-Lara, Citlaltepetl and Vargas-Robles, Hilda and Schnoor, Michael},
title = {Arpin deficiency increases actomyosin contractility and vascular permeability},
journal = {eLife},
year = {2024},
doi = {10.7554/elife.90692}
}
EUVIMED